Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Bodey

Showing results (491-500 of 726) with videos related to

Pageof 73
Sort By:
Archives of Internal Medicine|August 9, 1993
Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous accessI Raad, S Davis, M Becker, et al.
Cancer Chemotherapy Reports|August 1, 1972
Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adultsJ P Whitecar, G P Bodey, E J Freireich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1994
Infections due to Cunninghamella bertholletiae in patients with cancer: report of three cases and reviewD P Kontoyianis, S Vartivarian, E J Anaissie, et al.
Cancer|April 15, 1994
Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin BG P Bodey, E J Anaissie, L S Elting, et al.
The American Journal of Medicine|June 1, 1987
Pseudomonas putida. Newly recognized pathogen in patients with cancerE Anaissie, V Fainstein, P Miller, et al.
Cancer Research|December 1, 1977
A phase 1 and 2 trial of rubidazone in patients with acute leukemiaR S Benjamin, M J Keating, K B McCredie, et al.
Journal of Immunological Methods|December 17, 1985
Radioimmunoassay for etoposide and teniposideD H Ho, K S Kanellopoulos, N S Brown, et al.
Oncology|January 1, 1986
Phase II study of AMSA and doxorubicin to treat metastatic breast cancerM T Casimir, A U Buzdar, G R Blumenschein, et al.
Cancer|October 1, 1979
Neocarzinostatin: a phase I clinical trial with five-day intermittent and continuous infusionsE M McKelvey, M A Burgess, K B McCredie, et al.
Cancer Treatment Reports|January 1, 1981
Zinostatin-related pulmonary toxicityD B Calvo, S S Legha, E M McKelvey, et al.
Pageof 73

Showing results (491-500 of 726) with videos related to

Sort By:
Pageof 73
Archives of Internal Medicine|August 9, 1993
Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous accessI Raad, S Davis, M Becker, et al.
Cancer Chemotherapy Reports|August 1, 1972
Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adultsJ P Whitecar, G P Bodey, E J Freireich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1994
Infections due to Cunninghamella bertholletiae in patients with cancer: report of three cases and reviewD P Kontoyianis, S Vartivarian, E J Anaissie, et al.
Cancer|April 15, 1994
Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin BG P Bodey, E J Anaissie, L S Elting, et al.
The American Journal of Medicine|June 1, 1987
Pseudomonas putida. Newly recognized pathogen in patients with cancerE Anaissie, V Fainstein, P Miller, et al.
Cancer Research|December 1, 1977
A phase 1 and 2 trial of rubidazone in patients with acute leukemiaR S Benjamin, M J Keating, K B McCredie, et al.
Journal of Immunological Methods|December 17, 1985
Radioimmunoassay for etoposide and teniposideD H Ho, K S Kanellopoulos, N S Brown, et al.
Oncology|January 1, 1986
Phase II study of AMSA and doxorubicin to treat metastatic breast cancerM T Casimir, A U Buzdar, G R Blumenschein, et al.
Cancer|October 1, 1979
Neocarzinostatin: a phase I clinical trial with five-day intermittent and continuous infusionsE M McKelvey, M A Burgess, K B McCredie, et al.
Cancer Treatment Reports|January 1, 1981
Zinostatin-related pulmonary toxicityD B Calvo, S S Legha, E M McKelvey, et al.
Pageof 73